-
Resolution Liquid Biopsy Assay Demonstrates Fewer False Positives and Higher Positive Predictive Value Than Three Known Commercial ctDNA NGS Tests
Apr 9, 2019, 10:03 AM by Michael CroftKIRKLAND, WA, UNITED STATES - Apr 9, 2019 - Resolution Bioscience, Inc., today announced that a team of AstraZeneca scientists recently published results of a study looking at assay discordance and technical variations between four leading commercial next-generation sequencing (NGS) gene panelsFull story -
Avellino Labs Welcomes James (Jim) V. Mazzo to Its Board of Directors
Apr 9, 2019, 07:09 AM by Michael CroftMENLO PARK, CA, UNITED STATES - Apr 9, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) VFull story -
MDI Biological Laboratory to Hold Panel Discussion on the Opioid Crisis in Maine
Apr 8, 2019, 13:50 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Apr 8, 2019 - BAR HARBOR, MAINE -- The MDI Biological Laboratory and the University of New England (UNE) are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in MaineFull story -
Life Science Integrates launches new Bio Integrates to address the biggest challenges impacting the pharma and biotech sector
Apr 8, 2019, 11:20 AM by Michael CroftLONDON, UK - Apr 1, 2019 - Inspired by the success of Pharma Integrates, Life Science Integrates has introduced the new Bio Integrates conference, to be held at the Grange Tower Bridge Hotel, London, on the 22ndMay 2019Full story -
How Artificial Intelligence Will Impact Drug Development
Apr 8, 2019, 10:10 AM by Michael CroftFull storyBio-IT World | Artificial intelligence has the potential to stimulate and streamline drug discovery and development by increasing our understanding of complex biology, guiding drug design, and by assisting other more mundane elements of pharmaceutical R&D and regulatory affairs.
-
Quantabio Launches Single-Tube Lyophilized Reagent to Simplify Shipping, Storage and Setup of RT-qPCR RNA Applications
Apr 8, 2019, 09:55 AM by Michael CroftBEVERLY, MA, UNITED STATES - Apr 8, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today launched the Qscript lyo 1-step, a lyophilized single-reaction reagent optimized for highly sensitive and reproducible RT-qPCR RNA applicationsFull story -
HLA Typing With PacBio Shown To Improve Transplant Outcomes
Apr 5, 2019, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | Scientists at the Anthony Nolan Research Institute in the UK have demonstrated that ultra-high-resolution HLA typing performed with PacBio sequencing identified stronger matches associated with improved survival rates among patients who received hematopoietic stem cell transplants. The retrospective study was published this week in the Journal of Biology of Blood and Marrow Transplantation.
-
Greenphire Launches New Tax Capability to Ease Administrative Burden and Improve Compliance for Clinical Trial Industry
Apr 4, 2019, 15:55 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Apr 4, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has released a new tax capability for its customers, easing the administrative burden of reporting, tracking, and managing tax associated with participant paymentsFull story -
Data Visualization's Use In A Data-Driven World
Apr 4, 2019, 09:25 AM by Michael CroftFull storyBio-IT World | As medicine becomes frequently data-driven, data visualization will be key to the progress of its various fields.
-
WCG Announces the Acquisition of Analgesic Solutions, LLC
Apr 4, 2019, 08:48 AM by Michael CroftPRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying conditionFull story -
Medacta Opens IPO-Season 2019 at SIX
Apr 4, 2019, 04:42 AM by Michael CroftZURICH, SWITZERLAND - Apr 4, 2019 - Today, the shares of Medacta Group SA (ticker "MOVE") were traded for the first time at SIX, opening at CHF 104xFull story -
Discovery Life Sciences Acquires HudsonAlpha Genomic Services Lab
Apr 3, 2019, 07:35 AM by Michael CroftFull storyBio-IT World News Brief | Discovery Life Science has acquired the assets, technology and staff of the HudsonAlpha Genomic Services Laboratory (GSL). Financial terms were not disclosed, but the HudsonAlpha Institute is now a shareholder of Discovery Life Sciences.
-
Strata Oncology Launches Expanded StrataNGS for Patients with Advanced Cancer
Apr 2, 2019, 13:32 PM by Michael CroftBELFORD, NJ, US - Apr 1, 2019 - Strata Oncology Launches Expanded StrataNGS for Patients with Advanced CancerUpdated StrataNGS test analyzes 500 cancer genes and reports status for three key immunotherapy biomarkers to inform the use of precision therapiesANN ARBOR, MichFull story -
Australia: Moratorium On Genetic Test Results To Be Binding Life Industry Standard
Apr 2, 2019, 12:25 PM by Michael CroftFull storyAsia Insurance Review | From 1 July 2019, the Financial Services Council (FSC) will enact the moratorium on life insurance genetic test results as a binding standard, following stakeholder feedback on the FSC Life Insurance Code of Practice consultation.
-
CRF Bracket Industry Experts to Host Educational Seminar on Patient-First Technology in Clinical Trials
Apr 2, 2019, 09:55 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Apr 2, 2019 - CRF Bracket will host a complimentary half-day educational seminar on April 24th in Cambridge, MA, to share industry insights on patient-first technology in clinical trialsFull story -
Mologic expands US and UK operations
Apr 2, 2019, 08:28 AM by Michael CroftBEDFORDSHIRE, UNITED KINGDOM - Apr 1, 2019 -Full story- Strengthens team as part of continued international expansion
- Bolsters US presence with the opening of subsidiary in Boston, MA
- Doubles device manufacturing capacity in UK
-
Sterling Pharma Solutions announces acquisition of CiVentiChem in the US
Apr 2, 2019, 05:20 AM by Michael CroftNEWCASTLE, UK - Apr 2, 2019 - UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChems US facility located in Cary, North Carolina, USFull story -
ChargePoint Technology Launches Single Use Technology as part of Powder Transfer Solutions portfolio at INTERPHEX 2019
Apr 2, 2019, 04:23 AM by Michael Croft- Apr 1, 2019 - Contained and sterile transfer solutions expert, ChargePoint Technology today announces new, single use additions to its portfolio; the ChargePoint® Single Use Passive (SUP) and ChargeBag® PE-S with new HiPure ULP7 PE filmFull story -
GenScript, ReForm Biologics, Mission Bio, And More: News From March 2019
Apr 1, 2019, 12:55 PM by Michael CroftFull storyBio-IT World | March featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including GenScript, ReForm Biologics, Mission Bio, and more.
-
Illumina Files Patent Infringement Suit Against BGI In Germany
Mar 29, 2019, 12:55 PM by Michael CroftFull storyBio-IT World News Brief | Illumina announced that it has filed a patent infringement suit against BGI Group's subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany.